Literature DB >> 11600835

Elevated substance P levels in HIV-infected men.

S D Douglas1, W Z Ho, D R Gettes, A Cnaan, H Zhao, J Leserman, J M Petitto, R N Golden, D L Evans.   

Abstract

The neuropeptide, substance P, is a potent modulator of neuroimmunoregulation. Substance P and its receptor modulate HIV infection. HIV-seropositive men had significantly higher plasma substance P levels compared with uninfected controls, which were associated with decreased CD16 and CD56 natural killer (NK) cell populations. The changes in plasma substance P levels and decreases in NK subsets did not correlate with CD4 cell levels, but a diurnal pattern was suggested for substance P. The balance between substance P expression and functions of immune cells may be important in the immunopathogenesis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600835     DOI: 10.1097/00002030-200110190-00019

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  29 in total

1.  Measurement of plasma-derived substance P: biological, methodological, and statistical considerations.

Authors:  Donald E Campbell; Nancy Raftery; Richard Tustin; Nancy B Tustin; Michelle L Desilvio; Avital Cnaan; Pyone Pyone Aye; Andrew A Lackner; Steven D Douglas
Journal:  Clin Vaccine Immunol       Date:  2006-09-13

2.  Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.

Authors:  Mark M Manak; Dmitry A Moshkoff; Lequan T Nguyen; John Meshki; Pablo Tebas; Florin Tuluc; Steven D Douglas
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

Review 3.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

Review 4.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

5.  Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals.

Authors:  Steven D Douglas; Kevin G Lynch; Jian-Ping Lai
Journal:  J Neurol Sci       Date:  2008-06-24       Impact factor: 3.181

Review 6.  The role of quantitative pharmacology in an academic translational research environment.

Authors:  Jeffrey S Barrett
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

Review 7.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

8.  Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor.

Authors:  Mohammad M Khan; Steven D Douglas; Tami D Benton
Journal:  J Neuroimmunol       Date:  2011-11-23       Impact factor: 3.478

9.  Innate immune markers in mothers and fathers of children newly diagnosed with cancer.

Authors:  Meredith J Lutz Stehl; Anne E Kazak; Wei-Ting Hwang; Ahna L H Pai; Anne F Reilly; Steven D Douglas
Journal:  Neuroimmunomodulation       Date:  2008-08-05       Impact factor: 2.492

10.  HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P.

Authors:  Florin Tuluc; John Meshki; Sergei Spitsin; Steven D Douglas
Journal:  J Leukoc Biol       Date:  2014-02-27       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.